SAA spoke to Kate Nicholson, JD, founder and executive director of the…
SAA joined rheumatologists, researchers, and patient advocates from around the world November 12-14 in Philadelphia, PA for the…
Upadacitinib is approved for the treatment of adults with active nr-axSpA who have objective signs of inflammation, and…
Physical activity and exercise have long been considered an important part of…
Ustekinumab (Stelara), a biologic medication that inhibits the IL-12 and IL-23 cytokines, has gained FDA approval for the…
Consuming five to six prunes daily preserved bone density in postmenopausal women,…
Input your search keywords and press Enter.
